Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

plerixafor × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 43 Plasma cell 35 Other hematologic neoplasm 29 Myeloid 11 Sarcoma 5 CNS 5 Gastrointestinal 3 Dermatologic 2 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1

Conditions

Children Cancer, Solid Tumor 1

Interventions

Cisplatin 136 Carboplatin 115 pembrolizumab 113 Paclitaxel 94 Injections 90 Pemetrexed 88 Gemcitabine 80 Irinotecan 70 Cyclophosphamide 66 Docetaxel 61 Nivolumab 60 Bevacizumab 57 Fluorouracil 47 Oxaliplatin 45 Capecitabine 43 atezolizumab 41 Leucovorin 40 tislelizumab 37 Etoposide 36 toripalimab 30 fludarabine 28 Ipilimumab 28 Topotecan 26 Drug Therapy 26 Radiotherapy 25 durvalumab 24 Early Intervention, Educational 24 Vincristine 23 Doxorubicin 23 Specimen Handling 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01225419 2014-07-08

MEP1

University Hospital, Clermont-Ferrand

Phase 2 Completed

Other solid neoplasm

Children Cancer, Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡